[1]
2024. Impressive and Prolonged Response with Lenvatinib in a Highly Pretreated Patient with Metastatic Clear Cell Renal Cancer: A Case Report. Journal of Kidney Cancer. 11, 2 (Apr. 2024), 1–6. DOI:https://doi.org/10.15586/jkcvhl.v11i2.317.